Even clinicians who are not as familiar with these medications will ask me, 'I have a patient on Mounjaro who's not losing weight can we switch to Zepbound? without realizing its exactly the same drug. To complicate matters, pharmaceutical companies are quickly working on new drugs including triple agonists that target GLP-1, GIP and glucagon receptors as well as oral versions of each drug
Understanding Side Effects and Safety of GLP-1 Medications The most common side effects during GLP-1 therapy include mild nausea, constipation, and decreased appetitereactions that typically diminish within 2-4 weeks as your body adjusts
Manufacturers claim they can, for instance, help you build muscle, recover after a workout, or boost weight and fat loss
Prescribing it for alcohol dependence would be an off-label use that lacks sufficient clinical evidence
TCTP overexpression reverses age-associated telomere attrition by upregulating telomerase activity in mouse oocytes [J]
PMID: 30205948
